Profiling and Reversing Metabolic Insufficiency in the Tumor Microenvironment in Advanced Melanoma: A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Phase of Trial: Phase I
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Metformin (Primary) ; Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jan 2018 Status changed from not yet recruiting to recruiting.
- 21 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.